For example, a pharmaceutical company in diabetes medication, reported that there was a statistically significant reduction in type 1 diabetes when it tested its new insulin. The test consisted of 26 weeks of randomized therapy among diabetes patients, and the data gave a p-value that was less than 5%. This signifies to investors and regulatory agencies that the data show a statistically significant reduction in type 1 diabetes.